These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 32213021)

  • 1. Discriminant and convergent validity of the GSRS-IBS symptom severity measure for irritable bowel syndrome: A population study.
    Ljótsson B; Jones M; Talley NJ; Kjellström L; Agréus L; Andreasson A
    United European Gastroenterol J; 2020 Apr; 8(3):284-292. PubMed ID: 32213021
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Patients with irritable bowel syndrome-diarrhea have lower disease-specific quality of life than irritable bowel syndrome-constipation.
    Singh P; Staller K; Barshop K; Dai E; Newman J; Yoon S; Castel S; Kuo B
    World J Gastroenterol; 2015 Jul; 21(26):8103-9. PubMed ID: 26185382
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Latent structure of irritable bowel syndrome symptom severity.
    Jasper F; Egloff B; Roalfe A; Witthöft M
    World J Gastroenterol; 2015 Jan; 21(1):292-300. PubMed ID: 25574104
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Psychometric Evaluation of the Diary for Irritable Bowel Syndrome Symptoms-Constipation in a Prospective Observational Study.
    McLeod L; Ervin C; Fehnel SE; Eremenco S; Carson RT; Hanlon J; Coons SJ;
    Value Health; 2024 May; 27(5):614-622. PubMed ID: 38311181
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Design and validation of a German version of the GSRS-IBS - an analysis of its psychometric quality and factorial structure.
    Schäfer SK; Weidner KJ; Hoppner J; Becker N; Friedrich D; Stokes CS; Lammert F; Köllner V
    BMC Gastroenterol; 2017 Dec; 17(1):139. PubMed ID: 29202711
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Incidence of post-infectious irritable bowel syndrome and functional intestinal disorders following a water-borne viral gastroenteritis outbreak.
    Zanini B; Ricci C; Bandera F; Caselani F; Magni A; Laronga AM; Lanzini A;
    Am J Gastroenterol; 2012 Jun; 107(6):891-9. PubMed ID: 22525306
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cognitive and Behavioral Differences Between Subtypes in Refractory Irritable Bowel Syndrome.
    Windgassen S; Moss-Morris R; Everitt H; Sibelli A; Goldsmith K; Chalder T
    Behav Ther; 2019 May; 50(3):594-607. PubMed ID: 31030876
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An irritable bowel syndrome-specific symptom questionnaire: development and validation.
    Wiklund IK; Fullerton S; Hawkey CJ; Jones RH; Longstreth GF; Mayer EA; Peacock RA; Wilson IK; Naesdal J
    Scand J Gastroenterol; 2003 Sep; 38(9):947-54. PubMed ID: 14531531
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of the Irritable Bowel Syndrome Quality of Life (IBS-QOL) questionnaire in diarrheal-predominant irritable bowel syndrome patients.
    Andrae DA; Patrick DL; Drossman DA; Covington PS
    Health Qual Life Outcomes; 2013 Dec; 11():208. PubMed ID: 24330412
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of health related quality of life in irritable bowel syndrome patients.
    Jamali R; Jamali A; Poorrahnama M; Omidi A; Jamali B; Moslemi N; Ansari R; Dolatshahi S; Ebrahimi Daryani N
    Health Qual Life Outcomes; 2012 Jan; 10():12. PubMed ID: 22284446
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Psychometric validation of symptom severity measures in irritable bowel syndrome with constipation.
    Williams VS; Nelson LM; Fehnel SE; MacDougall J; Carson RT; Tourkodimitris S; Kurtz C; Baird MJ; Johnston JM
    Aliment Pharmacol Ther; 2014 Aug; 40(3):298-308. PubMed ID: 24943204
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sex-Related Differences in Clinical Symptoms, Quality of Life, and Biochemical Factors in Irritable Bowel Syndrome.
    Choghakhori R; Abbasnezhad A; Amani R; Alipour M
    Dig Dis Sci; 2017 Jun; 62(6):1550-1560. PubMed ID: 28374085
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of the alternating bowel habit subtype in patients with irritable bowel syndrome.
    Tillisch K; Labus JS; Naliboff BD; Bolus R; Shetzline M; Mayer EA; Chang L
    Am J Gastroenterol; 2005 Apr; 100(4):896-904. PubMed ID: 15784038
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Constipation and Constipation-predominant Irritable Bowel Syndrome: A Comparative Study Using Rome III Criteria.
    Rajindrajith S; Devanarayana NM; Benninga MA
    J Pediatr Gastroenterol Nutr; 2017 May; 64(5):679-684. PubMed ID: 27403609
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Importance of diarrhea in evaluating constipation in irritable bowel syndrome clinical studies.
    Basseri RJ; Kunkel D; Low K; Conklin JL; Pimentel M
    J Clin Gastroenterol; 2011 Oct; 45(9):790-3. PubMed ID: 21301356
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development of the Diary for Irritable Bowel Syndrome Symptoms to Assess Treatment Benefit in Clinical Trials: Foundational Qualitative Research.
    Fehnel SE; Ervin CM; Carson RT; Rigoni G; Lackner JM; Coons SJ;
    Value Health; 2017 Apr; 20(4):618-626. PubMed ID: 28408004
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Patients suspected of irritable bowel syndrome--cross-sectional study exploring the sensitivity of Rome III criteria in primary care.
    Engsbro AL; Begtrup LM; Kjeldsen J; Larsen PV; de Muckadell OS; Jarbøl DE; Bytzer P
    Am J Gastroenterol; 2013 Jun; 108(6):972-80. PubMed ID: 23419383
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Internet survey on the actual situation of constipation in the Japanese population under 70 years old: focus on functional constipation and constipation-predominant irritable bowel syndrome.
    Kawamura Y; Yamamoto S; Funaki Y; Ohashi W; Yamamoto K; Ozeki T; Yamaguchi Y; Tamura Y; Izawa S; Hijikata Y; Ebi M; Ogasawara N; Sasaki M; Kasugai K
    J Gastroenterol; 2020 Jan; 55(1):27-38. PubMed ID: 31428873
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Is-it possible to distinguish irritable bowel syndrome with constipation from functional constipation?
    Bouchoucha M; Devroede G; Bon C; Bejou B; Mary F; Benamouzig R
    Tech Coloproctol; 2017 Feb; 21(2):125-132. PubMed ID: 28066860
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of irritable bowel syndrome on patients' lives: development and psychometric documentation of a disease-specific measure for use in clinical trials.
    Longstreth GF; Bolus R; Naliboff B; Chang L; Kulich KR; Carlsson J; Mayer EA; Naesdal J; Wiklund IK
    Eur J Gastroenterol Hepatol; 2005 Apr; 17(4):411-20. PubMed ID: 15756093
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.